Evidence map›Paper›PMID 36280759›Full record

ArticleBone marrow transplantation2022

Correction: Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT.

Arnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, Myriam Labopin, Nicolaus Kröger, Gerard Socié, Tobias Gedde-Dahl, Victoria Potter, Thomas Schroeder, Uwe Platzbecker and 9 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 77% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 13 institutions in 7 countries.

Arnon NaglerDivision of Hematology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel. arnon.nagler@sheba.health.gov.il.ORCID http://orcid.org/0000-0002-0763-1265
Maud NgoyaEBMT Paris study office, Department of Haematology, Saint Antoine Hospital, INSERM UMR 938, Sorbonne University, Paris, France.ORCID http://orcid.org/0000-0002-7810-6900
Jacques-Emmanuel GalimardEBMT Paris study office, Department of Haematology, Saint Antoine Hospital, INSERM UMR 938, Sorbonne University, Paris, France.ORCID http://orcid.org/0000-0001-9102-4427
Myriam LabopinEBMT Paris study office, Department of Haematology, Saint Antoine Hospital, INSERM UMR 938, Sorbonne University, Paris, France.ORCID http://orcid.org/0000-0003-4514-4748
Nicolaus KrögerBone Marrow Transplantation Centre, University Hospital Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0001-5103-9966
Gerard SociéInserm U976, APHP, Hopital St. Louis, Dept. of Hematology-BMT, University of Paris, Paris, France.ORCID http://orcid.org/0000-0002-2114-7533
Tobias Gedde-DahlRikshospitalet Clinic for Cancer Medicine, Hematology Dept. Section for Stem Cell Transplantation, Oslo University Hospital, Oslo, Norway.
Victoria PotterKings College Hospital, Dept. of Haematological Medicine, King's Denmark Hill Campus, London, UK.
Thomas SchroederDept. of Bone Marrow Transplantation, University Hospital, Essen, Germany.
Uwe PlatzbeckerMedical Clinic and Policinic 1, Hematology and Cellular Therapy, University hospital, Leipzig, Germany.
Arnold GanserDepartment of Haematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Didier BlaiseProgramme de Transplantation & Therapie Cellulaire Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.ORCID http://orcid.org/0000-0002-5684-9447
Urpu SalmenniemiComprehensive Cancer Center, Stem Cell Transplantation Unit, HUCH, Helsinki, Finland.
Johan MaertensDept. of Hematology, University Hospital Gasthuisberg, Leuven, Belgium.
Charles CraddockQueen Elizabeth Medical Centre, Edgbaston, Dept. of Haematology, University Hospital Birmingham NHS Trust, Birmingham, UK.ORCID http://orcid.org/0000-0001-5041-6678
Hélène Labussière-WalletCentre Hospitalier Lyon Sud, Service Hematologie, Lyon, France.
Ibrahim Yakoub-AghaCHU de Lille, INSERM, Univ Lille, Lille, France.ORCID http://orcid.org/0000-0003-4524-8782
Bipin SavaniVanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0002-3304-9965
Mohamad MohtyEBMT Paris study office, Department of Haematology, Saint Antoine Hospital, INSERM UMR 938, Sorbonne University, Paris, France.ORCID http://orcid.org/0000-0002-7264-808X
Inserm · FRCentre de Recherche en Cancérologie de Marseille · FREssen University Hospital · DEHôpital Lyon Sud · FRKing's College Hospital · GBMedizinische Hochschule Hannover · DEOslo University Hospital · NOQueen Elizabeth Hospital Birmingham · GBSheba Medical Center · ILUniversitair Ziekenhuis Leuven · BEUniversität Hamburg · DEUniversity Hospital Leipzig · DEVanderbilt University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36280759
OpenAlexW4307286765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.